Call Options

31 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $9.66 Million - $10.9 Million
348,584 Added 10.86%
3,557,416 $103 Million
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $10.4 Million - $12.1 Million
410,298 Added 14.66%
3,208,832 $89.8 Million
Q1 2024

May 13, 2024

SELL
$25.89 - $29.73 $11.7 Million - $13.4 Million
-451,939 Reduced 13.9%
2,798,534 $77.7 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $41 Million - $53.3 Million
1,570,641 Added 93.5%
3,250,473 $93.6 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $27.1 Million - $31.7 Million
844,232 Added 101.03%
1,679,832 $55.7 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $12.4 Million - $14.3 Million
342,800 Added 69.56%
835,600 $30.6 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $14.9 Million - $19.4 Million
-379,000 Reduced 43.47%
492,800 $20.1 Million
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $34.6 Million - $45.1 Million
-828,300 Reduced 48.72%
871,800 $44.7 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $48.1 Million - $58.7 Million
1,099,000 Added 182.83%
1,700,100 $74.4 Million
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $14.7 Million - $17.5 Million
-316,300 Reduced 34.48%
601,100 $31.5 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $61.4 Million - $76.1 Million
-1,342,312 Reduced 59.4%
917,400 $47.5 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $67 Million - $99.3 Million
1,621,127 Added 253.86%
2,259,712 $133 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $9.69 Million - $12.4 Million
-246,803 Reduced 27.88%
638,585 $27.5 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $1.17 Million - $1.32 Million
32,503 Added 3.81%
885,388 $34.7 Million
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $17.2 Million - $19.4 Million
514,185 Added 151.81%
852,885 $30.9 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $10.4 Million - $13.2 Million
311,200 Added 1131.64%
338,700 $12.5 Million
Q3 2020

Nov 12, 2020

SELL
$31.75 - $37.25 $3.4 Million - $3.99 Million
-107,100 Reduced 79.57%
27,500 $1.01 Million
Q2 2020

Jul 31, 2020

BUY
$30.12 - $36.54 $641,556 - $778,302
21,300 Added 18.8%
134,600 $4.4 Million
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $4.25 Million - $6.07 Million
-157,300 Reduced 58.13%
113,300 $3.7 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $7.84 Million - $8.9 Million
238,300 Added 737.77%
270,600 $10.6 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $685,539 - $888,943
-21,100 Reduced 39.51%
32,300 $1.16 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $4.23 Million - $4.75 Million
-114,400 Reduced 68.18%
53,400 $2.31 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $12.7 Million - $14 Million
-338,700 Reduced 66.87%
167,800 $7.13 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $3.94 Million - $4.5 Million
-102,500 Reduced 16.83%
506,500 $22.1 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $9.09 Million - $11 Million
263,611 Added 76.32%
609,000 $26.8 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $5.66 Million - $6.03 Million
-171,611 Reduced 33.19%
345,389 $12.5 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $4.19 Million - $4.86 Million
-131,400 Reduced 20.27%
517,000 $18.3 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $10.9 Million - $11.6 Million
328,700 Added 102.82%
648,400 $23.5 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $8.11 Million - $8.94 Million
261,700 Added 451.21%
319,700 $11.4 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-251,064 Reduced 81.23%
58,000 $1.95 Million
Q1 2017

Nov 14, 2017

BUY
N/A
309,064
309,064 $10.6 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.